In vitro time course assays for four renal selective compounds.

Slides:



Advertisements
Similar presentations
Definition of measurements and patients Michael J. Murphy, et al. Br J Clin Pharmacol 2008;65:
Advertisements

Enhanced DNA damage in IDH1 mutant glioma cells.
Recombinant OPCML protein effect in vitro.
Comparison of cytokine profiles induced by ChiLob 7/4 and TLR ligands in ex vivo whole-blood stimulation assays. Comparison of cytokine profiles induced.
Concentrations of abemaciclib in plasma and cerebrospinal fluid (CSF).
Treatment with MI-773 causes changes in p53 status.
Drug levels during the course of a dosing interval.
MMAE resistance and intracellular accumulation.
Intrapatient variability in cyclosporine blood levels in renal transplant patients. Intrapatient variability in cyclosporine blood levels in renal transplant.
eNOS regulated IR-induced NO generation and EGFR signal activation.
Table A and B, in vitro synergy of romidepsin and pralatrexate (PDX) in TCL cell lines. Table A and B, in vitro synergy of romidepsin and pralatrexate.
Evaluation of top candidate clones for selective killing in bispecific antibody format. Evaluation of top candidate clones for selective killing in bispecific.
In vitro binding and specificity of OTL78.
In vitro invasion assays were done in the Chemicon invasion chamber containing extracellular matrix. In vitro invasion assays were done in the Chemicon.
Protein expression profile in a dasatinib-resistant cell line.
Colony-forming capacity of CD34+ cells with and without CLL-1 expression. Colony-forming capacity of CD34+ cells with and without CLL-1 expression. CD34+
Effect of anti-CYP3A and anti-CYP2C antibodies on the disappearance of MPA in human liver microsomes (GHL24). Effect of anti-CYP3A and anti-CYP2C antibodies.
Β-Cryptoxanthin at a concentration of 10 μmol/L decreases proliferation in HCT116 cells after 6 and 8 days of treatment. β-Cryptoxanthin at a concentration.
Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3
Pre- and post-vorinostat values of ER-related gene expression using the Oncotype DX 21-gene assay. Pre- and post-vorinostat values of ER-related gene expression.
Predictive value of the FGFR3 mutation assay increases with multiple consecutive FGFR3-positive urine samples. Predictive value of the FGFR3 mutation assay.
Measurement of free NO concentrations in culture medium after the addition of 1 mm NO-releasing compounds. Measurement of free NO concentrations in culture.
Study overview. Study overview. A, Schematic illustrating clinical trial design and the nature and number of tissue specimens available for downstream.
Tamoxifen-treated patients.
Induction of cytotoxic activity in humanized SCC3 tumor-bearing mice treated with anti-PD-1 antibody. Induction of cytotoxic activity in humanized SCC3.
Time course of a G2-M arrest in response to 6-TG compared with IR and VP-16, showing that 6-TG induced a delayed G2-M arrest in MMR+ cells. Time course.
Tipifarnib and bortezomib are synergistic in cytotoxicity assays
Immunologic and pharmacokinetic studies.
Duration of treatment and intervals of radiographic and ctDNA response
The effect of different concentrations of WMC-79 and time of exposure on the growth of HCT-116 cells. The effect of different concentrations of WMC-79.
A, P causes G2-M arrest with apoptosis in asynchronous population of PC-3 when exposed to 1.5 and 5 μmol/L P for various time points. A, P
Nested RT-PCR of Mammaglobin and CK19 mRNA in plasma and circulating cells of controls (C) and patients (T) with breast cancer. Nested RT-PCR of Mammaglobin.
NKT cell recognition of CD1d1 molecules is inhibited by treatment with ascites. NKT cell recognition of CD1d1 molecules is inhibited by treatment with.
Distribution of FGFR aberrancies in urothelial cancers.
Determination of MTD for romidepsin and pralatrexate and associated antitumor activity. Determination of MTD for romidepsin and pralatrexate and associated.
Effect of siltuximab on paclitaxel sensitivity in ovarian cancer drug resistant cells. Effect of siltuximab on paclitaxel sensitivity in ovarian cancer.
Mean cell number in small intestinal crypt (a), small intestinal villus (b), and midcolonic crypt (c) of BALB/c (♦) and DBA/2 (▪) mice after two injections.
Tivantinib behaves as an antimitotic agent.
6-TG dose and time relationships for DSB formation using PFGE, demonstrating that the formation of DSBs in both MMR+ M4 and MMR− V2 cells is dose dependent.
Free interstitial drug as a function of the initial load of soluble drug, ci0 and the intracellular binding capacity, bc,max. Free interstitial drug as.
PK profile of OTL78. PK profile of OTL78. A, Representative time-dependent whole-body fluorescence images over white light images of a mouse bearing 22Rv1.
Kaplan–Meier curves for RFS and OS by various marker groups.
Mean weight change from original weight of (a) BALB/c (b) DBA/2 mice after one (♦) or two (▴) injections of 10 mg/kg and one (▪) or two (×) injections.
Identification of compounds that enhance TMZ cytotoxicity in melanoma cells by screening the Spectrum Collection library. Identification of compounds that.
The effects of 5α-dihydrotestosterone and growth factors (insulin-like growth factor I and epidermal growth factor) on LNCaP cell proliferation. The effects.
Lesions and healthy organs dosimetry.
Association of overall survival and PAP-specific (A, B) and PA2024-specific (C, D) CTL activity at week 26 using categorical (tertile) analysis and continuous.
A, pretreatment CT scan of pelvic lymphadenopathy (identified by white arrow) in 1 patient with documented response to 1α-OH-D2. A, pretreatment CT scan.
Mean percentage change from baseline in total IGF-I and the R1507 serum concentration values following a single i.v. administration of R mg/kg (n.
Growth inhibition of HNSCC cells in vitro with curcumin
MGA271 mediates in vitro ADCC across a panel of ATCC cancer cell lines exhibiting a range of B7-H3 expression. MGA271 mediates in vitro ADCC across a panel.
VEGF165 stimulates migration of HMVECs
The best response for target lesions per patient for patients with target lesions assessed at baseline and at least 1 follow-up. The best response for.
Immunoblot analysis in PANC1 and MSTO-211H cells.
DFS and DSS curves according to low, intermediate, and high stromal CD8+ T-cell density in the four different cohorts; A and B, University Hospital of.
Antigen expression and Breslow thickness.
Effect of bevacizumab on the proliferation of A2780 cells.
Although equivalent experimental systems have been employed in a variety of assessments to determine BCR-ABL1 kinase domain mutation sensitivity on the.
Cellular pharmacology of F-ara-A and Cl-F-ara-A.
A, Proportion for different in silico predictions at the RNA level.
Flavopiridol inhibits rhabdoid cell survival and induces cell cycle arrest and apoptosis. Flavopiridol inhibits rhabdoid cell survival and induces cell.
A and B, linearity of the preamplification step shown by a similar expression pattern of ERα mRNA in four breast tumor samples pre– and post–linear amplification.
Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.
Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. A,
Plasma concentration-time profile after oral administration of a single dose. Plasma concentration-time profile after oral administration of a single dose.
Mechanism by which flavopiridol induces cell cycle arrest and apoptosis in rhabdoid tumor cells. Mechanism by which flavopiridol induces cell cycle arrest.
(A) Twenty-four-hour plasma profiles of insulin and amylin in healthy subjects. (A) Twenty-four-hour plasma profiles of insulin and amylin in healthy subjects.
miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro.
Genotype-specific combinatorial drug sensitivities in melanoma.
DHA and dietary n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in xenograft models. DHA and dietary n-3 PUFAs inhibit endometrial cancer.
Presentation transcript:

In vitro time course assays for four renal selective compounds. In vitro time course assays for four renal selective compounds. Renal line A498 was exposed to a wide range of concentrations for various times. Profiles of activity demonstrate that all agents confer near maximum activity with brief drug exposures (≤3 h) to similar drug concentrations (with the possible exception of NSC 281613, which appears to require somewhat higher molar drug concentrations at the shorter intervals). Susan D. Mertins et al. Clin Cancer Res 2001;7:620-633 ©2001 by American Association for Cancer Research